HEM1036 Phase 2 Study in Low Anterior Resection Syndrome
Phase 2
Not yet recruiting
- Conditions
- LARS - Low Anterior Resection Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- HEM Pharma Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT05527301
© Copyright 2025. All Rights Reserved by MedPath